Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis

  • 0Department of Neuromuscular Diseases, National Neurological Institute "C. Besta," 20133 Milan, Italy.

Abstract

Read the full abstract on PubMed

Related Concept Videos